Boston Scientific receives approval
Boston Scientific Corporation recently received US Food and Drug Administration approval for its Genesys HTA System for the treatment of menorrhagia.
Boston Scientific Corp. has announced it has agreed to acquire BridgePoint Medical, according to a news release.